Rhythm Biosciences Ltd (ASX: RHY) Acquires Genetype Business
Rhythm Biosciences (ASX: RHY) has acquired Genetype assets, enhancing its oncology portfolio and positioning for immediate revenue growth.
Rhythm Biosciences (ASX: RHY) has acquired Genetype assets, enhancing its oncology portfolio and positioning for immediate revenue growth.
FBR Limited successfully completes its US Demonstration Program, paving the way for an exclusive joint venture for construction robots.
Mach7 Technologies Limited (ASX:M7T) announces the signing of A$4.6M in new contracts to enhance its PACS solutions and future revenue growth.
Emmerson Resources Limited (ASX: ERM) updates on its completed drilling at the White Devil Gold Project, with more results expected in early 2025.
Galileo Mining reports significant assay results from its Norseman project, revealing promising PGE mineralization and plans for future exploration.
Capral (ASX:CAA) has upgraded its FY24 earnings guidance due to improved market conditions.
Epsilon Healthcare Limited (ASX:EPN) outlines its ambitious targets and operational capabilities, aiming for $14M revenue growth.
Midway Limited (ASX: MWY) announces court approval for a scheme meeting regarding its acquisition by RCM BidCo.
Transurban Group (ASX:TCL) updates on ConnectEast litigation while reaffirming distribution guidance for FY25.
IRIS Metals Limited (ASX:IR1) announces final assays from Beecher Project, confirming significant lithium intersections and future production plans.